Calendar AlzeCure Pharma AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 16:29:47 15/05/2024 BST			5-day change	1st Jan Change
1.785 ^SEK	+0.28%		0.00%	-42.60%

05-14	AlzeCure Pharma AB Approves the Election of Jan Lundberg as New Ordinary Members of the Board of Directors	CI
04-25	AlzeCure Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

6f48c567.hxe3gRz0yRjvi4Qnedoo_Niqgf-b4sSOPNAjiT0TwN4.63_6tSyT8Sza-vVjTo1AyKHH5pLVjIXjEbMTukRRtKb9L--1d8asUornwQ~ffdc0dfd760bd1bcffbd539c4973a103

25/08/2024	Q2 2024 Earnings Release
10/11/2024	Q3 2024 Earnings Release
26/02/2025	Q4 2024 Earnings Release (Projected)
30/04/2025	Q1 2025 Earnings Release (Projected)
20/08/2025	Q2 2025 Earnings Release (Projected)
05/11/2025	Q3 2025 Earnings Release (Projected)

13/05/2024	Annual General Meeting
01/05/2024	Q1 2024 Earnings Release
04/03/2024	Alzheimer and Parkinson Diseases International Conference
27/02/2024 07:20	Q4 2023 Earnings Release
08/02/2024 15:40	EQT Life Sciences Bio Capital Europe Investor Conference
14/12/2023 17:50	Redeye Investor Forum
06/12/2023 19:30	Nordic American Healthcare Conference
23/11/2023 10:40	Redeye Life Science Day
09/11/2023 07:15	Q3 2023 Earnings Release
23/10/2023	CTAD International Alzheimer Conference
11/10/2023 09:45	Redeye Neurology Theme Event
19/09/2023	EFIC Conference
24/08/2023 07:20	Q2 2023 Earnings Release
01/06/2023 13:10	Redeye Growth Day
25/05/2023 13:05	Penser Market Conference
17/05/2023 09:00	Capital Markets Day
16/05/2023	Annual General Meeting
04/05/2023	Q1 2023 Earnings Release
24/02/2023 07:20	Q4 2022 Earnings Release
28/11/2022	Alzheimer Conference - Abstract No. AC-0027875

Fiscal Period	December	2019	2020	2021	2022	2023	2024
Net sales Million SEK	Released Forecast Spread	0,00	0,00	0,00 0,00 -	0,00	0,00 0,00 -	0,00
EBITDA Million SEK	Released Forecast Spread	0,00	0,00	-77,4 -75,5 -2.49%	0,00	-37,8 -36,0 -4.96%	-46,5
EBIT Million SEK	Released Forecast Spread	0,00	0,00	-77,9 -76,0 -2.51%	0,00	-38,3 -36,0 -6.28%	-46,5
Earnings before Tax (EBT) Million SEK	Released Forecast Spread	0,00	0,00	-77,8 -75,9 -2.41%	0,00	-37,2 -36,0 -3.24%	-46,5
Net income Million SEK	Released Forecast Spread	-50,9	-71,4	-77,8 -75,9 -2.41%	-56,2	-37,2 -36,0 -3.24%	-46,5
EPS SEK	Released Forecast Spread	-1,35	-1,89	-2,06 -2,01 -2.49%	-1,18	0,00 0,00 -	0,30
Announcement Date		28/02/20	26/02/21	24/02/22	24/02/23	27/02/24	-

15/05/2024	BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 14:00	ZEALAND PHARMA A/S: Q1 2024 Earnings Release
17/05/2024 12:00	AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
23/07/2024	VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024	BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00	ARGENX SE: Q2 2024 Earnings Release
29/07/2024	RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024	NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024	CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024	CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)

Today	CELCUITY INC.: Q1 2024 Earnings Release
13/05/2024	IMMATICS N.V.: Q1 2024 Earnings Release (Projected)
13/05/2024	ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
13/05/2024	PEPTIDREAM INC.: Q1 2024 Earnings Release
13/05/2024	NYKODE THERAPEUTICS: Q1 2024 Earnings Release
13/05/2024	ABL BIO INC.: Q1 2024 Earnings Release (Projected)
13/05/2024	LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release (Projected)
13/05/2024 21:01	ALLOGENE THERAPEUTICS, INC.: Q1 2024 Earnings Release
12/05/2024	PHARMAESSENTIA CORPORATION: Q1 2024 Earnings Release
12/05/2024	INNOCARE PHARMA LIMITED: Q1 2024 Earnings Release